How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

15 results for

Emergency Pediatric Dosing 19-22 kilogram

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Emergency Pediatric Dosing 19-22 kilogram

Emergency Pediatric Dosing 19-22 kilogram Emergency Pediatric Dosing 19-22 kilogram Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 (...) Emergency Pediatric Dosing 19-22 kilogram Emergency Pediatric Dosing 19-22 kilogram Aka: Emergency Pediatric Dosing 19-22 kilogram , Broselow Blue II. Criteria: Body habitus Age: 5-6 years Length: 110 to 122 cm Weight: 19-22 kg (mean 21 kg) III. Findings: Vital Signs (normal) : 65-135/minute : 20-30/minute Systolic : 80-110 mmHg IV. Medications: Rapid Sequence Intubation (RSI) and intubation and ventilation Induction (Sedation) 6.3 mg 42 mg 63 mg Paralytic 40 mg 21 mg 2.1 mg Sedation Maintenance 1 mg

2018 FP Notebook

2. Emergency Pediatric Dosing 19-22 kilogram

Emergency Pediatric Dosing 19-22 kilogram Emergency Pediatric Dosing 19-22 kilogram Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 (...) Emergency Pediatric Dosing 19-22 kilogram Emergency Pediatric Dosing 19-22 kilogram Aka: Emergency Pediatric Dosing 19-22 kilogram , Broselow Blue II. Criteria: Body habitus Age: 5-6 years Length: 110 to 122 cm Weight: 19-22 kg (mean 21 kg) III. Findings: Vital Signs (normal) : 65-135/minute : 20-30/minute Systolic : 80-110 mmHg IV. Medications: Rapid Sequence Intubation (RSI) and intubation and ventilation Induction (Sedation) 6.3 mg 42 mg 63 mg Paralytic 40 mg 21 mg 2.1 mg Sedation Maintenance 1 mg

2015 FP Notebook

3. CPG on Attention Deficit Hyperactivity Disorder (ADHD) in the Child and Adolescent Population

CPG on Attention Deficit Hyperactivity Disorder (ADHD) in the Child and Adolescent Population Clinical Practice Guideline on Attention De? cit Hyperactivity Disorder (ADHD) in Children and Adolescents CLINICAL PRACTICE GUIDELINES IN THE SPANISH NATIONAL HEALTHCARE SYSTEM MINISTRY OF HEALTH, SOCIAL POLICY , AND EQUALITY MINISTERIO DE SANIDAD, POLÍTICA SOCIAL E IGUALDADIt has been 5 years since the publication of this Clinical Practice Guideline and it is subject to updating. Clinical Practice (...) disorder (ADHD) in Children and Adolescentsis the fruit of this request. ADHD is a disorder that has a neurobiological origin, starting in childhood and whose symp- toms can last until adult age.It is one of the psychiatric disorders with greatest prevalence and the one that records the largest number of consultations due to the enormous consequences in the different aspects of the patient’s life.Over the last few years, it has been one of the most highly- researched disorders, due to the potential

2010 GuiaSalud

4. Janus Kinase Inhibitors and Biosimilars for Rheumatoid Arthritis: Effectiveness and Value

be aware that new evidence may emerge following the publication of this report that could potentially influence the results. ICER may revisit its analyses in a formal update to this report in the future. The economic models used in ICER reports are intended to compare the clinical outcomes, expected costs, and cost effectiveness of different care pathways for broad groups of patients. Model results therefore represent average findings across patients and should not be presumed to represent the clinical (...) are different. A proposed biosimilar must have the same mechanism of action for the intended condition(s) of use as the reference product. The route of administration, dose form, and strength must also be the same. Of note, once a biosimilar has been approved, it may be prescribed for any indication allowed for the reference product, even if the biosimilar has not been studied in that patient population. 29 Biosimilar naming follows a standard approach. Each nonproprietary name for a biological product

2020 California Technology Assessment Forum

5. Heart Disease and Stroke Statistics Full Text available with Trip Pro

tax was greatest among households of the lowest socioeconomic status. A similar 1 cent per ounce excise tax on SSBs was implemented in Berkeley, California, in January 2015, and SSB sales declined by 9.6% after 1 year compared with predicted SSB purchases based on pretax trends. The Special Supplemental Nutrition Program for Women, Infants, and Children food package was revised in 2009 to include more fruits, vegetables, whole grains, and lower-fat milk. These food package revisions were (...) after myocardial infarction (MI), lower risk of atrial fibrillation, and greater positive psychological functioning (dispositional optimism). Among children, from 1999 to 2000 to 2015 to 2016, prevalence of nonsmoking, ideal total cholesterol, and ideal BP improved. For example, nonsmoking among children aged 12 to 19 years went from 76% to 94%. However, meeting ideal levels for physical activity, body mass index (BMI), and blood glucose did not improve. For example, prevalence of ideal BMI declined

2019 American Heart Association

6. Management of Uterine Fibroids

for classification as poor quality included: no description or unclear description of randomization method (4 studies), 98,118,138,145 no report of assessment of medication adherence, 128 and failure to blind outcome assessors. 94,98 Eleven studies included a placebo or no treatment comparison group 36,65,67,74,106,118,123,128,129,147,150 . Eight studies compared two or more medications 73,84,87,102,124,133,136,149,153 and 10 compared doses of the same drug. 54,64,66,75,79,88,119,123,140,146 Several studies (...) evaluated dose schedules or regimens that change over time. Another eight studies 94,98,122,138,142,144,145,151 examined the role of an additional drug (i.e., add-back) given to decrease the side effects of the primary GnRH treatment. Six studies of medical interventions are discussed in other sections of this report: the placebo arm of two studies are discussed in the section on expectant management, because the active agents (tibolone, asoprisnil) are not approved for use in the United States; 139 103

2017 Effective Health Care Program (AHRQ)

8. Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiac arrest in patients at risk

, public places, and/or used by medical emergency staff during resuscitation [1] (B0001). The LifeVest ® system is indicated for patients 18 years of age and older who are at risk for SCA and are not candidates for or refuse an ICD [5]. The device first received an FDA approval in 2001 and in 2015, it received the FDA approval also for children who are at risk for SCA, but are not candidates for an ICD due to certain medical conditions or lack of parental consent [9]. The WCD claims to offer temporary (...) ) No evidence available (D0010) No evidence available (D0017) No evidence available (H0203) Inappropriate shocks: 2% of patients [18] and 0.5% of patients [22], 0% of patients [19-21] Unsuccessful shocks: 0.7% of patients [18], 0% of patients [19, 20, 22] Frequency of SAEs leading to death: 0.3% of patients [18], 0% of patients [19-22] (C0008) Lacking Skin rash and itching: 6% of patients [18] False alarms: 14% of patients [19] Palpitations, light-headedness and fainting: 9% of patients [21] Discontinuation

2016 EUnetHTA

9. Translarna - ataluren

was circulated to all CHMP members on 22 April 2014. • The Rapporteurs circulated the Joint Assessment Report on the applicant’s detailed grounds for re-examination to all CHMP members on 8 May 2014. • During the CHMP meeting on 19-22 May 2014, the detailed grounds for re-examination were addressed by the applicant during oral explanations before the CHMP. • During the meeting on 19-22 May 2014, the CHMP, in the light of the scientific data available and the scientific discussion within the Committee (...) development were to develop an immediate release solid oral dosage form of Ataluren suitable for consumption by paediatric patients and young adults. After initial clinical studies using powder in bottle formulation, granules for suspension were selected as the commercial dosage form since these would allow reconstitution in liquid media (water, milk, fruit juice) or semi-solid media (yoghurt, pudding, or apple sauce) for ease of administration to the youngest patients. The active substance shows pH

2014 European Medicines Agency - EPARs

10. Exercise Standards for Testing and Training Full Text available with Trip Pro

, despite increasing oxygen uptake. In most cases, the ventilatory threshold is highly reproducible, although it might not be achieved or readily identified in some patients, particularly those with very poor exercise capacity. It is convenient to express oxygen uptake in multiples of resting oxygen requirements—that is, METs, whereby a unit of sitting/resting oxygen uptake (1 MET) is defined as ≈3.5 mL O 2 per kilogram of body weight per minute (mL kg −1 min −1 ). For example, an oxygen uptake (...) to ≈6 kilopond-meters per minute (kpm/min). Because exercise on a cycle ergometer is not weight bearing, kiloponds or watts can be converted to oxygen uptake in milliliters per minute. METs are obtained by dividing o 2 in milliliters per minute by the product of body weight (in kilograms) × 3.5. The cycle ergometer is usually less expensive, occupies less space, and is less noisy than a treadmill. Upper body motion is usually reduced, making it easier to obtain blood pressure measurements

2013 American Heart Association

11. Assessment and Management of Foot Ulcers for People with Diabetes, Second Edition

skin changes Ulceration Amputation Poor healing • Self-care deficit • Poor glucose control • Improper footwear • Obesity • Lack of timely resources Infection17 BEST PRACTICE GUIDELINES • www.RNAO.ca BACKGROUND Assessment and Management of Foot Ulcers for People with Diabetes, Second Edition The management of persons with foot ulcers is complex. According to Weir (2010), diabetic foot ulcers should be regarded a medical emergency. Principles of clinical management of the person with diabetic foot

2013 Registered Nurses' Association of Ontario

12. KDIGO Clinical Practice Guideline for Acute Kidney Injury

therapy in patients with AKI 111 Chapter 5.8: Dose of renal replacement therapy in AKI 113 Biographic and Disclosure Information 116 Acknowledgments 122 References 124 http://www.kidney-international.org contents & 2012 KDIGO VOL 2|SUPPLEMENT 1|MARCH 2012TABLES Table 1. Implications of the strength of a recommendation 18 Table 2. Staging of AKI 19 Table 3. Comparison of RIFLE and AKIN criteria for diagnosis and classification of AKI 21 Table 4. Cross-tabulation of patients classified by RIFLE vs. AKIN (...) in AKD and CKD 35 Table 14. Integrated approach to interpret measures of kidney function and structure for diagnosis of AKI, AKD, and CKD 35 Table 15. CI-AKI risk-scoring model for percutaneous coronary intervention 73 Table 16. Additional radiological measures to reduce CI-AKI 77 Table 17. Potential applications for RRT 91 Table 18. Fluid overload and outcome in critically ill children with AKI 91 Table 19. Overview of the advantages and disadvantages of different anticoagulants in AKI patients 97

2012 National Kidney Foundation

13. Management of pancreatic exocrine insufficiency: Australasian Pancreatic Club recommendations Full Text available with Trip Pro

12 Children (6 months to 3 years) 500–4000 units lipase per gram of dietary fat 11 OR 1000 units lipase per kilogram of bodyweight per meal 12 * 10 000 units lipase per kilogram of bodyweight per day 12 Infants (< 6 months) 500–1000 units lipase per gram of dietary fat 11 OR 2000–4000 units lipase per breastfeed or per 120 mL of infant formula 12 10 000 units lipase per kilogram of bodyweight per day 12 * Enzyme doses should be halved for snacks. James Toouli 1 Andrew V Biankin 2 Mark R Oliver 3 (...) exocrine insufficiency Adapted from Domínguez-Muñoz. 4 Recommended doses of pancreatic enzyme replacement therapy in patients with pancreatic exocrine insufficiency Age group Initial recommended dose Maximum recommended dose Adults (≥ 18 years) 25 000–40 000 units lipase per meal 8,10 * 75 000–80 000 units lipase per meal 8,10 Children (4–17 years) 500–4000 units lipase per gram of dietary fat 11 OR 500 units lipase per kilogram of bodyweight per meal 12 * 10 000 units lipase per kg bodyweight per day

2010 MJA Clinical Guidelines

14. ACR-ASNR Practice Guideline for the Performance and Interpretation of Cervicocerebral Computed Tomography Angiography (CTA)

. The radiation exposure to the patient should be minimized within the limits of acceptable image quality, including optimization of kVp and mAs. If infants and children are being imaged, there should be written guidelines for acceptable CT radiation exposure, including weight-appropriate or age-appropriate guidelines to reflect the as-low-as-reasonably-achievable (ALARA) principle. Dose modulation approaches can be used, with appropriate targeted signal-to-noise ratio. Because of substantial variations (...) necessary. In children, contrast medium dosing should be scaled to body weight. Injection rate should be scaled similarly and preferably delivered via powered injection. The volume of contrast medium should be selected with consideration of the patient’s weight and comorbidities that might increase the risk of nephrotoxicity. When performing cervicocerebral CTA, a right-arm injection is preferable to a left-arm injection to avoid artifacts from undiluted contrast medium in the left brachiocephalic vein

2010 American Society of Neuroradiology

15. X-ray Full Text available with Trip Pro

million on children. Avoiding unnecessary X-rays (especially CT scans) reduces radiation dose and any associated cancer risk. Medical X-rays are a significant source of man-made radiation exposure. In 1987, they accounted for 58% of exposure from man-made sources in the . Since man-made sources accounted for only 18% of the total radiation exposure, most of which came from natural sources (82%), medical X-rays only accounted for 10% of total American radiation exposure; medical procedures as a whole (...) is called the : The (Gy), which has units of (joules/kilogram), is the SI unit of , and it is the amount of radiation required to deposit one of energy in one of any kind of matter. The is the (obsolete) corresponding traditional unit, equal to 10 millijoules of energy deposited per kilogram. 100 rad= 1 gray. The is the measure of the biological effect of radiation on human tissue. For X-rays it is equal to the . The (rem) is the traditional unit of equivalent dose. For X-rays it is equal

2012 Wikipedia

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>